First there were regular insulins, then intermediate-acting NPH insulins, then long-acting, and most recently ultra long-acting, which is actually still a daily product. So what’s this about a possible once-weekly insulin? Wouldn’t that blow the other so-called long-acting products out of the water? Perhaps it’s time to judge with journal club.

Read More